Holen Sie sich die Stockscreener-App
1.27
0.79%
0.01
Schlusskurs vom Vortag:
$1.26
Offen:
$1.28
24-Stunden-Volumen:
37,398
Relative Volume:
0.14
Marktkapitalisierung:
$50.30M
Einnahmen:
$41.21M
Nettoeinkommen (Verlust:
$-15.12M
KGV:
-3.5288
EPS:
-0.3599
Netto-Cashflow:
$-17.19M
1W Leistung:
+2.42%
1M Leistung:
-19.11%
6M Leistung:
+57.49%
1J Leistung:
+13.39%
1-Tages-Spanne:
$1.2601
$1.305
1-Wochen-Bereich:
$1.20
$1.33
52-Wochen-Spanne:
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
Firmenname
Myomo Inc
Sektor
Branche
Telefon
617-996-9058
Adresse
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.27 | 50.30M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
98.69 | 170.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.41 | 119.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.16 | 64.01B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-20 | Eingeleitet | Lake Street | Buy |
| 2023-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Dougherty & Company | Buy |
| 2017-10-02 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Myomo Inc Aktie (MYO) Neueste Nachrichten
Myomo, Inc. (MYO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Myomo CMO Harry Kovelman sells $20,136 in company stock By Investing.com - Investing.com South Africa
Myomo CMO Harry Kovelman sells $20,136 in company stock - Investing.com
Form 4 Myomo Inc: Harry Kovelman (Chief Medical Officer) For: 11 September - Investing.com Nigeria
Form 4 Myomo Inc: Harry Kovelman (Chief Medical Officer) For: 11 September - Investing.com UK
Myomo CMO Harry Kovelman sells $20,136 in company stock By Investing.com - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 13 October - Investing.com Nigeria
Form 4 Myomo Inc: Paul R. Gudonis (Director, CEO) For: 13 October By Investing.com - Investing.com South Africa
Myomo CEO Paul R. Gudonis Awarded 71,250 RSUs on October 13, 2026 - Kalkine Media
Form 4 Myomo Inc: Paul R. Gudonis (Director, CEO) For: 9 October - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Canada
To pay taxes only, Myomo (MYO) officer plans to sell 3,133 shares as stock grants vest. - Stock Titan
Form 4 Myomo Inc: Mary-Katherine Hale McClure (Chief Commericial Officer) For: 12 October - Investing.com India
Myomo appoints Mary-Katherine McClure as chief commercial officer - Investing.com
Myomo Names Mary-Katherine McClure as Chief Commercial Officer - Yahoo Finance
Myomo names new chief commercial officer effective October 2026 - StreetInsider
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer - Yahoo Finance
Q1 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Myomo Inc (HAM:0M61) DCF Valuation - GuruFocus
Myomo Inc (HAM:0M61) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Myomo Inc Stock Operating Data - GuruFocus
Myomo Inc (HAM:0M61) Stock Price, Trades & News - GuruFocus
Spotlight On 3 Penny Stocks With Market Caps As Low As $10M - Simply Wall Street
Tangible book value per share of Myomo, Inc. – HAN:0M61 - TradingView
Discontinued operations of Myomo, Inc. – HAN:0M61 - TradingView
Preferred dividends of Myomo, Inc. – HAN:0M61 - TradingView
0M61 Forecast — Price Target — Prediction for 2027 - TradingView
Myomo Q2 2026 Earnings Call Transcript - Benzinga
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeZero Lag EMA - dars.gov.et
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com India
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionEarnings Yield Analysis - dars.gov.et
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares - Investing.com
Finanzdaten der Myomo Inc-Aktie (MYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Myomo Inc-Aktie (MYO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HARRY KOVELMAN | Officer |
Sep 11 '26 |
Proposed Sale |
1.27 |
15,844 |
20,136 |
0 |
| Kovelman Harry | Chief Medical Officer |
Sep 11 '26 |
Sale |
1.27 |
15,488 |
19,684 |
90,245 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Proposed Sale |
1.41 |
15,000 |
21,150 |
0 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Sale |
1.41 |
15,000 |
21,150 |
208,391 |
| Kovelman Harry | Chief Medical Officer |
Aug 20 '26 |
Sale |
1.73 |
17,250 |
29,896 |
105,983 |
| HARRY KOVELMAN | Officer |
Aug 20 '26 |
Proposed Sale |
1.73 |
17,500 |
30,329 |
0 |
| David Henry | Officer |
Jul 13 '26 |
Proposed Sale |
1.09 |
5,166 |
5,631 |
0 |
| Micah Mitchell | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
9,061 |
10,873 |
0 |
| Harry Kovelman | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
10,442 |
12,530 |
0 |
| Micah Mitchell | Officer |
Jun 08 '26 |
Proposed Sale |
1.33 |
6,529 |
8,684 |
0 |
1.83%
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):